0

Pulmonary Hypertension Collection
 1-20 of 48 Articles
Articles |  21 October 2008
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized Trial
Gérald Simonneau, MD; Lewis J. Rubin, MD; Nazzareno Galiè, MD; et al.
Ann Intern Med. 2008;149(8):521-530. doi:10.7326/0003-4819-149-8-200810210-00004
Editorials |  21 October 2008
Therapy for Pulmonary Arterial Hypertension: The More, the Merrier?
Darren B. Taichman, MD, PhD
Ann Intern Med. 2008;149(8):583-585. doi:10.7326/0003-4819-149-8-200810210-00010
Reviews |  19 February 2008
Narrative Review: The Enigma of Pulmonary Arterial Hypertension: New Insights from Genetic Studies
John H. Newman, MD; John A. Phillips, MD; James E. Loyd, MD
Ann Intern Med. 2008;148(4):278-283. doi:10.7326/0003-4819-148-4-200802190-00006
Reviews |  16 August 2005
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
Lewis J. Rubin, MD; David B. Badesch, MD
Ann Intern Med. 2005;143(4):282-292. doi:10.7326/0003-4819-143-4-200508160-00009
Articles |  2 April 2002
Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension
Hossein Ardeschir Ghofrani, MD; Ralph Wiedemann, MD; Frank Rose, MD; et al.
Ann Intern Med. 2002;136(7):515-522. doi:10.7326/0003-4819-136-7-200204020-00008
Articles |  21 March 2000
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease: A Randomized, Controlled Trial
David B. Badesch, MD; Victor F. Tapson, MD; Michael D. McGoon, MD; et al.
Ann Intern Med. 2000;132(6):425-434. doi:10.7326/0003-4819-132-6-200003210-00002
Articles |  21 March 2000
Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial
Horst Olschewski, MD; H. Ardeschir Ghofrani, MD; Thomas Schmehl, PhD; et al.
Ann Intern Med. 2000;132(6):435-443. doi:10.7326/0003-4819-132-6-200003210-00003
Editorials |  21 March 2000
Epoprostenol (Prostacyclin) and Pulmonary Hypertension
Alfred P. Fishman, MD
Ann Intern Med. 2000;132(6):500-502. doi:10.7326/0003-4819-132-6-200003210-00013
Brief Communications |  4 May 1999
Compassionate Use of Continuous Prostacyclin in the Management of Secondary Pulmonary Hypertension: A Case Series
Vallerie V. McLaughlin, MD; Diane E. Genthner, RN, BSN; Maureen M. Panella, RN, BSN; et al.
Ann Intern Med. 1999;130(9):740-743. doi:10.7326/0003-4819-130-9-199905040-00014
Brief Communications |  16 March 1999
Pulmonary Hypertension after Splenectomy?
Marius M. Hoeper, MD; Jost Niedermeyer, MD; Frank Hoffmeyer, MD; et al.
Ann Intern Med. 1999;130(6):506-509. doi:10.7326/0003-4819-130-6-199903160-00014
Brief Communications |  1 December 1996
Pulmonary Hypertension Developing after Alglucerase Therapy in Two Patients with Type 1 Gaucher Disease Complicated by the Hepatopulmonary Syndrome
Arthur Dawson, MD; Darlene J. Elias, MD; David Rubenson, MD; et al.
Ann Intern Med. 1996;125(11):901-904. doi:10.7326/0003-4819-125-11-199612010-00005
Brief Communications |  1 May 1996
Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension
Horst Olschewski, MD; Dieter Walmrath, MD; Ralph Schermuly, PhD; et al.
Ann Intern Med. 1996;124(9):820-824. doi:10.7326/0003-4819-124-9-199605010-00006
Reviews |  1 June 1995
The Eosinophilia-Myalgia Syndrome: Status of 205 Patients and Results of Treatment 2 Years after Onset
Phillip A. Hertzman, MD; Daniel J. Clauw, MD; Lee D. Kaufman, MD; et al.
Ann Intern Med. 1995;122(11):851-855. doi:10.7326/0003-4819-122-11-199506010-00008
Articles |  15 September 1994
Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin
Robyn J. Barst, MD; Lewis J. Rubin, MD; Michael D. McGoon, MD; et al.
Ann Intern Med. 1994;121(6):409-415. doi:10.7326/0003-4819-121-6-199409150-00003
Editorials |  15 September 1994
Prostacyclin and Primary Pulmonary Hypertension
Stuart Rich, MD
Ann Intern Med. 1994;121(6):463-464. doi:10.7326/0003-4819-121-6-199409150-00012
Brief Reports |  1 July 1993
Hypothyroidism and Primary Pulmonary Hypertension: An Autoimmune Pathogenetic Link?
David B. Badesch, MD; Kristine M. Wynne, RN, BSN; Scott Bonvallet, MD; et al.
Ann Intern Med. 1993;119(1):44-46. doi:10.7326/0003-4819-119-1-199307010-00008
Articles |  1 June 1992
Pulmonary Hypertension Predicts Mortality and Morbidity in Patients with Dilated Cardiomyopathy
Sandra V. Abramson, MD; James F. Burke, MD; John J. Kelly, MD; et al.
Ann Intern Med. 1992;116(11):888-895. doi:10.7326/0003-4819-116-11-888
Articles |  1 September 1991
Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry
Gilbert E. D'Alonzo, DO; Robyn J. Barst, MD; Stephen M. Ayres, MD; et al.
Ann Intern Med. 1991;115(5):343-349. doi:10.7326/0003-4819-115-5-343
Articles |  15 March 1991
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
Duncan J. Stewart, MD; Robert D. Levy, MD; Peter Cernacek, MD; et al.
Ann Intern Med. 1991;114(6):464-469. doi:10.7326/0003-4819-114-6-464
Articles |  1 April 1990
Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol): Results of a Randomized Trial
Lewis J. Rubin, MD; Jessica Mendoza, BSN; Michele Hood, BSPh; et al.
Ann Intern Med. 1990;112(7):485-491. doi:10.7326/0003-4819-112-7-485
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)